SAVA - Cassava Sciences gains on dividend distribution
2023-12-12 12:15:42 ET
More on Cassava Sciences
- Cassava Sciences - How To Interpret 3 'Positive' Updates Shared In Q3
- Cassava Sciences: Likely Potential Opportunity From Phase 3 Readout Next Year
- Cassava Sciences' Simufilam Does Not Appear To Be Effective Against Alzheimer's Disease
- Cassava Sciences Q3 costs rise amid late-stage Alzheimer’s program
- Cassava Sciences GAAP EPS of -$0.61 beats by $0.29
For further details see:
Cassava Sciences gains on dividend distribution